OWLT · Owlet, Inc.
$5.26
+0.02 (+0.38%)
At close · Jul 27
Going-concern doubt
— flagged May 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements included in this quarterly report on Form 10-Q are issued.”View the 10-Q filed May 11, 2026
Market Cap
$152.26M
Shares
29.00M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.30
Open$5.23
Day$5.02–5.46
52W$4.19–16.94
Avg vol 30d206K
Short int522K · 1.8% float · 2.9d
Short vol19%
Last earningsAug 11, 2026
DataNov 2020–Jul 2026
Filing10-Q · May 11
Up next
Next earnings call
Aug 11, 2026
Scheduled
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−40%
below
Price vs 50-day avg
−3%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
9%
near low
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−59%
trailing
YTD return
−67%
this year
Relative strength
−65%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
6 of 67 funds reported for Jun 30 · net +70.9K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.80% of float · ▲ +8.0% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
67 holders — mid 3-yr range
Squeeze score
47
elevated · 0–100
Fundamentals
Revenue growth
+35%
Y/Y
Gross margin
51%
expanding
EPS growth
+65%
Y/Y
Free cash flow
$-11.1M
Balance sheet
$22.4M
net cash
Quant / Vol
risk profile
Volatility
87%
annualized · 1-yr
Max drawdown
−73%
past year
ATR
8.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 7, 2026
Total revenue
· full year 2026
Initiated
$118M – $122M
prior FY $105.71M
midpoint +13.5% Y/Y
Gross margins
· full year 2026
Initiated
50% – 52%
Adjusted EBITDA
· full year 2026
Non-GAAP
Initiated
$7M – $9M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−40%
Bearish
Price vs 50-day avg
−3%
Neutral
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
9%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
6 of 67 funds reported for Jun 30 · net +70.9K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.80% of float · ▲ +8.0% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
67 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $4
Now $5 · 9%
52-wk high $17
vs 200-day avg -40%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$1.5M | first quarter of 2026 | — |
|
|
|||
| paying subscribers | 115,000 | the first quarter | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OWLT
this stock
Owlet, Inc.
|
$152.26M | -67.3% | +35.4% | — | 1.8% |
|
ABT
Abbott Laboratories
|
$179.51B | -19.2% | +5.7% | 28.9 | 1.4% |
|
SYK
Stryker Corp
|
$126.60B | -9.0% | +11.2% | 38.2 | 1.8% |
|
MDT
Medtronic plc
|
$106.51B | -13.9% | +8.4% | 22.3 | 1.5% |
|
BSX
Boston Scientific Corp
|
$65.77B | -54.3% | +5.5% | 18.5 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OWLT | -8.5% | -5.4% | -58.5% | -7.7% | -67.3% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -6.8% | -6.0% | -64.9% | -6.5% | -75.5% |